Unit of Biostatistics

Selected Projects

best publications in the last three years

• • Cardinale D, Sandri MT, Colombo A, Salvatici M, Tedeschi I, Bacchiani G, Beggiato M, Meroni CA, Civelli M, Lamantia G, Colombo N, Veglia F, Casiraghi M, Spaggiari L, Venturino M, Cipolla CM. Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery. The PRESAGE Trial. Ann Surg. 2016;264(2):244-251.
  • Corrà U, Agostoni P, Piepoli MF; MECKI score research group. Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure. Int J Cardiol. 2015;184:299-301.
  • Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, Fiorentini C, Cipolla CM. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981-1988.
  • Zimmermann E, et al. Is the adiposity-associated FTO gene variant related to all-cause mortality independent of adiposity? Meta-analysis of data from 169,551 Caucasian adults. Obes Rev. 2015;16(4):327-340.
  • Swerdlow DI, et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015;385(9965):351-361.
  • Veglia F, Amato M, Giovannardi M, Ravani A, Tedesco CC, Frigerio B, Sansaro D, Tremoli E, Baldassarre D. Potentially spurious correlations between arterial size, flow-mediated dilation, and shear rate. Hypertension. 2014;64(6):1328-1333.
  • Mahajan A, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nature Genetics 2014;46(3):234-244.

Staff

• Calogero C. Tedesco, MSc

  Simone Barbieri, MSc

  Alice Bonomi, PhD student

  Eleonora Ecca, MSc